Onderneming Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Aandelen
301096
CNE1000056N5
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
71,1 CNY | -1,04% | +3,25% | +9,22% |
Vakgebied
Aantal werknemers: 1 321
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Transformation of Independent Research and Development Technological Achievements
38,6
%
| 221 | 36,4 % | 392 | 38,6 % | +77,66% |
Preclinical Pharmaceutical Research
33,2
%
| 218 | 36,0 % | 338 | 33,2 % | +54,81% |
Clinical Services
19,0
%
| 80 | 13,2 % | 193 | 19,0 % | +141,25% |
CDMO
5,2
%
| 21 | 3,4 % | 52 | 5,2 % | +152,35% |
Equity Share
2,9
%
| 58 | 9,5 % | 30 | 2,9 % | -48,74% |
Others
1,2
%
| 10 | 1,6 % | 12 | 1,2 % | +24,41% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 607 | 100,0 % | 1 017 | 100,0 % | +67,51% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jin Fang Lou
CEO | Chief Executive Officer | 56 | 01-08-15 |
Dong Bo Yan
DFI | Director of Finance/CFO | 33 | 01-02-23 |
43 | - | ||
35 | - | ||
Fei Jia
BRD | Director/Board Member | 45 | 13-12-18 |
Hui Ye
BRD | Director/Board Member | 38 | 01-05-17 |
Yi Fan Liu
BRD | Director/Board Member | 39 | 01-10-15 |
Chun Neng Shao
BRD | Director/Board Member | 56 | 01-06-11 |
Yi Xu
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hui Lin Li
BRD | Director/Board Member | 67 | 26-06-19 |
Yong Zhou Hu
BRD | Director/Board Member | 74 | 26-06-19 |
Jin Fang Lou
CEO | Chief Executive Officer | 56 | 01-08-15 |
Chun Neng Shao
BRD | Director/Board Member | 56 | 01-06-11 |
Yi Fan Liu
BRD | Director/Board Member | 39 | 01-10-15 |
Cheng Ren
BRD | Director/Board Member | 48 | 20-06-20 |
Bo Fan Song
CHM | Chairman | 35 | 01-01-15 |
Fu Miao Hu
CHM | Chairman | 43 | 01-04-16 |
Fei Jia
BRD | Director/Board Member | 45 | 13-12-18 |
Hong Bing Yan
BRD | Director/Board Member | 48 | 17-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 108 919 903 | 54 969 803 ( 50,47 %) | 777 300 ( 0,7136 %) | 50,47 % |
Bedrijfsgegevens
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.
159 Oasis Road Donghu Street
311103, Hangzhou
+
http://www.hzbio-s.comSector
Verkoop per activiteit
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,22% | 1,08 mld. | |
+24,96% | 46,71 mld. | |
+48,83% | 41,8 mld. | |
-1,21% | 41,52 mld. | |
-5,86% | 29,55 mld. | |
+10,40% | 25,78 mld. | |
-20,82% | 19,26 mld. | |
+2,09% | 12,14 mld. | |
-3,34% | 12,08 mld. | |
+28,16% | 11,98 mld. |
- Beurs
- Aandelen
- Koers 301096
- Onderneming Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.